By Peter A. McCullough, MD, MPH
The human body makes thousands of normal proteins recognized to be our own by the immune system. These proteins maintain housekeeping of the cells, build up structures like muscle, and breakdown other proteins such as digestive enzymes. The beautiful system can go awry when the body recognizes an internal produced protein that is foreign. This is the disastrous result of blunderous groupthink by mRNA “inventors” who conceived of using RNA coding for an abnormal protein to be inserted in the body letting our own cells produce it and then brace for the auto-immune attack.
There are many classes of antibodies and our particular attention with respect to respiratory pathogens is with IgA found in secretions protecting the nasopharynx and urogenital tract. When IgA is aberrantly produced and circulatory in the human body it can attack the lining of blood vessel cells, skin, lungs, and kidneys.
Ramdani, from Tours, France, reported on 12 cases of COVID-19 vaccine induced IgA vasculitis confirmed by skin biopsy with an array of manifestations including kidney damage. The clinical clue was the vasculitic skin rash. I was shocked to read that several patients pushed their luck with boosters potentially provoking even more severe organ injury. All the patients received treatment and relapses were infrequent.
The major points of this paper are: 1) auto-immune disease will happen after genetic vaccinations of any type and IgA vasculitis is just the tip of the iceberg, 2) skin rashes can be the only clue to internal organ damage and the need for treatment.
If you find “Courageous Discourse” enjoyable and useful to your endeavors, please subscribe as a paying or founder member to support our efforts in helping you engage in these discussions with family, friends, and your extended circles.
Ramdani Y, Bettuzzi T, Bouznad A, Delaitre L, Nassarmadji K, Didier K, Paul C, Liozon E, Tieu A, Richard-Colmant G, Terrier B, Moulis G, Lafaurie M, Pillebout E, Maillot F, Audemard-Verger A. IgA Vasculitis Following COVID-19 Vaccination: A French Multicenter Case Series Including 12 Patients. J Rheumatol. 2023 Feb;50(2):252-257. doi: 10.3899/jrheum.220545. Epub 2022 Nov 1. PMID: 36319000.